The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Enterotoxigenic Bacteroides fragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p
Abstract
BACKGROUD & AIMS Enterotoxigenic Bacteroides fragilis (ETBF) is strongly associated with the occurrence of inflammatory bowel disease(IBD), colitis-associated colorectal cancer (CAC) and colorectal cancer (CRC). However, the mechanism of ETBF-induced intestinal inflammation and tumorigenesis remains unclear. METHODS microRNA sequencing was utilized to detect the differentially expressed miRNAs both in ETBF-treated cells and exosomes derived from ETBF-inoculated cells. Cell Counting Kit-8 assays were used to evaluate the effect of ETBF and exosomes on CRC cell proliferation. The biological role and mechanism of ETBF-mediated miR-149-3p in colitis and colon carcinogenesis were determined both in vitro and in vivo. RESULTS ETBF promoted CRC cell proliferation by down-regulating miR-149-3p both in vitro and in vivo. ETBF-downregulated miR-149-3p depended on METTL14-mediated m6A methylation. As the target gene of miR-149-3p, PHF5A transactivated SOD2 through regulating KAT2A mRNA alternative splicing after ETBF treatment in CRC cells. miR-149-3p could be released in exosomes and mediated intercellular communication by modulating Th17 differentiation. The level of plasma exosomal miR-149-3p was gradually decreased from healthy control to IBD and CRC patients. MiR-149-3p, existing in plasma exosomes, negatively correlated with the abundance of ETBF in IBD and CRC patients. CONCLUSIONS Exosomal miR-149-3p derived from ETBF-treated cells facilitated Th17 cell differentiation. ETBF-induced colorectal carcinogenesis depended on downregulating miR-149-3p and further promoting PHF5A-mediated RNA alternative splicing of KAT2A in CRC cells. targeting the ETBF/miR-149-3p pathway presents a promising approach to treat intestinal inflammatory and colorectal cancer patients with high amount of ETBF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Bartel, D. P. (2018) · Cell · doi:10.1016/j.cell.2018.03.006 · Cited by 3,751
Shen, S., Park, J. W., Lu, Z.-X., Lin, L., Henry, M. D., Wu, Y. N., Zhou, Q., & Xing, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419161111 · Cited by 2,713
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Regulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260
Epigenetics and the environment: emerging patterns and implications
Feil, R., & Fraga, M. F. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3142 · Cited by 1,929
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Melo, S. A., Sugimoto, H., O’Connell, J. T., Kato, N., Villanueva, A., Vidal, A., Qiu, L., Vitkin, E., Perelman, L. T., Melo, C. A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.005 · Cited by 1,531
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
Yang, Y., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.018 · Cited by 1,008
Self-citationMa, J., Yang, F., Zhou, C., Liu, F., Yuan, J., Wang, F., Wang, T., Xu, Q., Zhou, W., & Sun, S. (2017) · Hepatology · doi:10.1002/hep.28885 · Cited by 912
microRNA Regulation of Inflammatory Responses
O'Connell, R. M., Rao, D. S., & Baltimore, D. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075013 · Cited by 843
Microbes, Microbiota, and Colon Cancer
Sears, C. L., & Garrett, W. S. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.007 · Cited by 818
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0230-y · Cited by 813
Gionchetti, P., Dignass, A., Danese, S., Magro Dias, F. J., Rogler, G., Lakatos, P. L., Adamina, M., Ardizzone, S., Buskens, C. J., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw169 · Cited by 771
MicroRNAs — the micro steering wheel of tumour metastases
Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S., & Calin, G. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2619 · Cited by 749
Chung, L., Thiele Orberg, E., Geis, A. L., Chan, J. L., Fu, K., DeStefano Shields, C. E., Dejea, C. M., Fathi, P., Chen, J., Finard, B. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.01.007 · Cited by 644
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Isolation and Characterization of RNA-Containing Exosomes
Lässer, C., Eldh, M., & Lötvall, J. (2012) · Journal of Visualized Experiments · doi:10.3791/3037 · Cited by 509
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin
Weaver, C. T., Elson, C. O., Fouser, L. A., & Kolls, J. K. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130318 · Cited by 462
Sun, T.-T., He, J., Liang, Q., Ren, L.-L., Yan, T.-T., Yu, T.-C., Tang, J.-Y., Bao, Y.-J., Hu, Y., Lin, Y., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0921 · Cited by 397
Self-citationZhang, J., Bai, R., Li, M., Ye, H., Wu, C., Wang, C., Li, S., Tan, L., Mai, D., Li, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09712-x · Cited by 381
MicroRNA-mediated regulation of T helper cell differentiation and plasticity
Baumjohann, D., & Ansel, K. M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3494 · Cited by 360
Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis
Sears, C. L., Geis, A. L., & Housseau, F. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72334 · Cited by 353
Medina-Contreras, O., Geem, D., Laur, O., Williams, I. R., Lira, S. A., Nusrat, A., Parkos, C. A., & Denning, T. L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59150 · Cited by 325
Herrinton, L. J., Liu, L., Levin, T. R., Allison, J. E., Lewis, J. D., & Velayos, F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.054 · Cited by 307
Animal Models of Inflammatory Bowel Disease
(2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-394596-9.00009-3 · Cited by 267
Kalla, R., Ventham, N. T., Kennedy, N. A., Quintana, J. F., Nimmo, E. R., Buck, A. H., & Satsangi, J. (2015) · Gut · doi:10.1136/gutjnl-2014-307891 · Cited by 267
Regulation of Gut Inflammation and Th17 Cell Response by Interleukin-21
Fina, D., Sarra, M., Fantini, M. C., Rizzo, A., Caruso, R., Caprioli, F., Stolfi, C., Cardolini, I., Dottori, M., Boirivant, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.041 · Cited by 265
Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations
Cretu, C., Schmitzová, J., Ponce-Salvatierra, A., Dybkov, O., De Laurentiis, E. I., Sharma, K., Will, C. L., Urlaub, H., Lührmann, R., & Pena, V. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.036 · Cited by 244
Guo, S., Chen, J., Chen, F., Zeng, Q., Liu, W.-L., & Zhang, G. (2021) · Gut · doi:10.1136/gutjnl-2020-321187 · Cited by 226
Geis, A. L., Fan, H., Wu, X., Wu, S., Huso, D. L., Wolfe, J. L., Sears, C. L., Pardoll, D. M., & Housseau, F. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0447 · Cited by 195
Scheibe, K., Backert, I., Wirtz, S., Hueber, A., Schett, G., Vieth, M., Probst, H. C., Bopp, T., Neurath, M. F., & Neufert, C. (2017) · Gut · doi:10.1136/gutjnl-2015-310374 · Cited by 188
Brosi, R., Gröning, K., Behrens, S., Lührmann, R., & Krämer, A. (1993) · Science · doi:10.1126/science.8211112 · Cited by 182
Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis
Rabizadeh, S., Rhee, K., Wu, S., Huso, D. L., Gan, C. M., Golub, J. E., Wu, X., Zhang, M., & Sears, C. L. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20265 · Cited by 157
miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD
Wu, W. H., He, C., Liu, C., Cao, A., Xue, X., Evans‐Marin, H., Sun, M., Fang, L., Yao, S., Pinchuk, I. V., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307980 · Cited by 156
Li, T., Su, L., Lei, Y., Liu, X., Zhang, Y., & Liu, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645333 · Cited by 130
Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination
Kathania, M., Khare, P. S., Zeng, M., Cantarel, B. L., Zhang, H., Ueno, H., & Venuprasad, K. (2016) · Nature Immunology · doi:10.1038/ni.3488 · Cited by 130
Wang, Z., Yang, X. P., Liu, C., Li, X., Zhang, B., Wang, B., Zhang, Y., Song, C., Zhang, T., Liu, M., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.009 · Cited by 129
Self-citationBasset, C., Holton, J., Bazeos, A., Vaira, D., & Bloom, S. L. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000042241.13489.88 · Cited by 121
Zhang, M., Gao, D., Shi, Y., Wang, Y., Joshi, R., Yu, Q., Liu, D., Alotaibi, F., Zhang, Y., Wang, H., et al. (2019) · Open Biology · doi:10.1098/rsob.190061 · Cited by 82
Inhibition of IL-17 as a Pharmacological Approach for IBD
Fitzpatrick, L. R. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.821118 · Cited by 46
Microbiota organization—a key to understanding CRC development
Hold, G. L., & Garrett, W. S. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.25 · Cited by 40
PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma
Yang, Y. F., Zhu, J., Zhang, T., Liu, J., Li, Y., Zhu, Y., Xu, L., Wang, R., Su, F., Ou, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0736-0 · Cited by 39
Zerumbone Restores Gut Microbiota Composition in ETBF Colonized AOM/DSS Mice
Cho, H., Rhee, K., & Eom, Y. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2006.06034 · Cited by 14
Cited by
Gut microbiota in colorectal cancer development and therapy
Wong, C. C., & Yu, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00766-x · Cited by 721
RNA modifications: importance in immune cell biology and related diseases
Cui, L., Ma, R., Cai, J., Guo, C., Chen, Z., Yao, L., Wang, Y., Fan, R., Wang, X., & Shi, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01175-9 · Cited by 405
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Zhao, L.-Y., Mei, J.-X., Yu, G., Lei, L., Zhang, W.-H., Liu, K., Chen, X.-L., Kołat, D., Yang, K., & Hu, J.-K. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01406-7 · Cited by 359
Kong, C., Liang, L., Liu, G., Du, L., Yang, Y., Liu, J., Shi, D., Li, X., & Ma, Y. (2023) · Gut · doi:10.1136/gutjnl-2022-327156 · Cited by 254
Self-citationZhang, Z., Tanaka, I., Pan, Z., Ernst, P. B., Kiyono, H., & Kurashima, Y. (2022) · European Journal of Immunology · doi:10.1002/eji.202149532 · Cited by 69
Metadata
- Authors
- Cao, Y., Wang, Z., Yan, Y., Ji, L., He, J., Xuan, B., Shen, C., Ma, Y., Jiang, S., Ma, D., Tong, T., Zhang, X., Gao, Z., Zhu, X., Fang, J.-Y., Chen, H., & Hong, J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 161
- Issue
- 5
- Pages
- 1552-1566.e12
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W3187291031
- Cited by
- 298
- References
- 52
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.